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Lessons Learned
• In aging, the blood brain barrier begins to weaken, facilitating the allowance of a large spectrum of pathogens (viruses, bacteria, fungi), 
immune cells, and their products into the brain
• Dietary changes, such as including more vegetables containing polyphenols and monounsaturated fatty acids has shown to be beneficial 
in improving verbal fluency and memory
• Variation of gut microbiota through personalized diet or beneficial microbiota intervention alter microbes and their products, including 
amyloid protein, and may prove to become a novel approach to the treatment and potential slowing of the effects of Alzheimer’s Disease
• Over time, various conditions lead to an inflammatory response shift from beneficial to detrimental in the form of systemic chronic 
inflammation, specifically in the brain
• Aβ deposits as well as varying microbes and their products (LPS, amyloids) crossing into the brain might be an initiating factor of the 
neuroinflammation and neurodegenerative changes observed in Alzheimer’s Disease
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ABSTRACT
The gut microbiome consists of the shared
genome of the community of trillions of
commensal, symbiotic, and pathogenic
microorganisms residing in the gastrointestinal
ecosystem. The interaction between the host and
its gut microbiome, as well as the Gut-Bran Axis
(GBA), is a complex relationship whose
management could prove critical to preventing or
treating not only various gut disorders, such as
irritable bowel syndrome (IBS) or behavioral health
disorders like general depression and anxiety, but
also central nervous system (CNS) disorders,
such as Alzheimer's (AD) and Parkinson's (PD)
diseases. The purpose of this review is to
summarize what is currently known about the gut
microbiome, how it is connected to the
development of disease pathology and to identify
the bacterial and biochemical targets/pathways
that should be the focus of future research. In
identifying, exploring, and understanding the
mechanisms behind the activity and propagation
of the gut microbiome, this will provide us new
insights that are likely to pave the way for
increased novel therapeutic strategies.
• Dysbiosis in the gut microbiome and microbial metabolites is known to be
associated with abnormalities in the gut mucosal barrier integrity and enhanced
pro-inflammatory cytokines
• Changes in the aging gut microbiome that impact the gut-brain axis can also lead
to problems with neural, endocrine, nutrient, and immunological signals between
the gut and the brain via the enteric nervous system
• It is possible to use a pro-biotics, pre-biotics, and psycho-biotics as a treatment
to aid in slowing psychological/behavioral decline linked to gut dysbiosis or
signaling problems between the ENS/CNS
• It has been found that Fecalibacterium and Butyricoccus, which are potentially
probiotic genera associated with inflammation suppression, and butyrate
production, respectively, were higher in cognitively unimpaired subjects
• Psycho-biotics are beneficial bacteria (a class of probiotics) or support for such
bacteria (prebiotics) that influence bacteria–brain relationships
• Elevated serum levels of C-reactive protein (CRP) in middle age is associated
with an increased risk for both Alzheimer’s Disease and vascular dementia,
which supports the theory that inflammatory markers are involved in dementia
and act through both peripheral and cerebral vascular pathways
• Age-related changes in microbial composition and metabolism are consistent
with the concept of “inflamm-aging,” which associates chronic low-grade
inflammation as a common basis for a widespread range of age-related
pathologies, including cognitive decline, neurodegeneration general CNS disease
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The bi-directional relationship of the gut/gut microbiota and the brain/central nervous 
system (CNS).
Modified from: https://www.straightfromascientist.com/the-microbiota-gut-brain-axis-from-eubiosis-to-dysbiosis-and-back-useful-biomarkers-for-clinical-treatment/figure-2-miguels/
Areas of the brain affected by CNS-based disease pathologies and medications/therapies commonly used to treat symptoms in affected 
persons.
Modified from: https://www.mdpi.com/2076-3425/8/9/177/htm
Interaction of the host health and immune function, diet, neurotransmitters,
metabolites, environmental factors, and the gut microbiome as it pertains to the
pathology of Alzheimer’s Disease.
Modified from: https://link.springer.com/article/10.1007/s12035-018-1188-4
Several inflammatory factors such as cytokines and endotoxins, as well as neurotransmitters, and
antimicrobial peptides, play a significant role in the development or potential mitigation of various
pathologies and are present and active in the gut microbiota.
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